epirubicin has been researched along with Thrombopenia in 56 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (14.29) | 18.7374 |
| 1990's | 23 (41.07) | 18.2507 |
| 2000's | 16 (28.57) | 29.6817 |
| 2010's | 7 (12.50) | 24.3611 |
| 2020's | 2 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, AG; Chacko, RT; Georgy, JT; Joel, A; John, AO; Premkumar, PS; Sharma, P; Singh, A | 1 |
| Ahari, A; Chawla, SP; Chua, V; Krkyan, N; Moradkhani, A; Osada, A; Riedel, RF | 1 |
| Li, S; Liang, Y; Ren, L; Tang, P; Wang, S; Wu, X; Zhang, T; Zhang, Y; Zhong, L | 1 |
| Funakoshi, T; Hirai, I; Ishii, M; Kawakami, Y; Nakamura, Y; Tanese, K | 1 |
| Blohmer, JU; Costa, SD; Eidtmann, H; Fasching, PA; Gerber, B; Hanusch, C; Hilfrich, J; Höß, C; Huober, J; Jackisch, C; Khandan, F; Kittel, K; Krabisch, P; Kümmel, S; Loibl, S; Mau, C; Minckwitz, Gv; Nekljudova, V; Rezai, M; Schwedler, K; Tesch, H; Untch, M | 1 |
| Boukovinas, I; Christophyllakis, C; Georgoulias, V; Kakolyris, S; Malamos, N; Mavroudis, D; Papakotoulas, P; Politaki, E; Polyzos, A; Tryfonidis, K; Xenidis, N | 1 |
| Chi, Y; Song, Y; Wang, J; Yang, L; Zhou, A | 1 |
| Li, J; Li, Y; Lu, M; Shen, L; Zhang, XD | 1 |
| Anderson, JR; Dasgupta, R; Gupta, AA; Hawkins, DS; Indelicato, DJ; Pappo, AS; Spunt, SL | 1 |
| Chen, LP; Lin, SJ; Yu, MS | 1 |
| Barni, S; Berardi, R; Beretta, GD; Cascinu, S; Catalano, V; D'Angelo, A; Franciosi, V; Graziano, F; Labianca, R; Martignoni, G; Salvagni, S; Scartozzi, M; Silva, RR; Zaniboni, A | 1 |
| Bonneterre, J; Catimel, G; Tubiana-Hulin, M | 1 |
| Chamorey, E; Delwail, V; Fabbro, M; Foussard, C; Gressin, R; Harrousseau, JL; Lepeu, G; Maisonneuve, H; Peyrade, F; Richard, B; Rossi, JF; Thyss, A; Vilque, JP | 1 |
| Dolezal, J; Dolezel, M; Moravek, P; Odrazka, K; Petera, J; Prosvic, P; Simakova, E; Vaculikova, M; Vosmik, M; Zoul, Z | 1 |
| Fujii, M; Hirota, S; Maruta, T; Matsumoto, S; Nakanishi, K; Ohno, Y; Saigo, K; Sugimura, K; Takenaka, D; Yoshikawa, T | 1 |
| Bu, Q; Cai, QQ; Gao, Y; Guan, ZZ; Huang, HQ; Jiang, WQ; Lin, XB; Pan, ZH; Wang, BF; Xia, ZJ; Xu, RH | 1 |
| Adjei, AA; Aubry, MC; Delaune, R; Foster, NR; Kardinal, CG; Maurer, MJ; Nikcevich, DA; Northfelt, DW; Okuno, SH; Rowland, KM; Sloan, JA; Soori, GS | 1 |
| Ahmed, T; Benedetto, P; Needles, B; Watson, RC; Yagoda, A | 1 |
| Grunenberg, B; Krischke, W; Niederle, N; Schmidt, CG; Schütte, J; Seeber, S | 1 |
| Bellanova, B; Camaggi, CM; Giovannini, M; Martini, A; Martoni, A; Monetti, N; Pannuti, F; Rossini, G; Tarquinii, M; Tomasi, L | 1 |
| Adachi, K; Horikoshi, N; Ikeda, K; Inagaki, J; Inoue, K; Nakada, K; Ogawa, M; Okada, Y; Tada, A; Usui, N | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; Talavera, A | 1 |
| Chevallier, B; Chollet, P; Fargeot, P; Fizames, C; Fumoleau, P; Genot, JY; Kerbrat, P; Merrouche, Y; Olivier, JP; Roche, H | 1 |
| Igawa, M; Kadena, H; Ueda, M; Usui, T | 1 |
| Akesson, M; Andersson, H; Friberg, LG; Horvath, G; Johansson, O; Westberg, R | 1 |
| Antilli, A; Ardizzoni, A; Bruzzi, P; De Marinis, F; Mariani, GL; Pallotta, G; Pennucci, MC; Rosso, R; Rubagotti, A; Salvati, F | 1 |
| Aglietta, M; Carnino, F; Gavosto, F; Monzeglio, C; Pasquino, P; Stern, AC | 1 |
| Burghouts, JT; Conroy, T; de Graeff, A; Fickers, M; Lalisang, F; Paillot, B; Roelofs, EJ; Wagener, DJ; Wils, J | 1 |
| Hofmann, J; Müller, T; Steck, T | 1 |
| Bianco, AR; Curcio, C; D'Aprile, M; Gebbia, V; Gridelli, C; Palmeri, S; Pepe, R; Pistillucci, G; Rossi, A; Veltri, E | 1 |
| Fosså, SD; Heilo, A; Hernes, EH; Ogreid, P; Paus, E; Vaage, S | 1 |
| Adachi, I; Kanda, K; Murai, H; Ogita, M; Saeki, T; Sano, M; Sasaki, Y; Shimoyama, M; Tabei, T; Takashima, S; Watanabe, T | 1 |
| Baù, MG; Berruti, A; Bottini, A; Buniva, T; Danese, S; Dogliotti, L; Farris, A; Moro, G; Porcile, G; Richiardi, G; Zola, P | 1 |
| Cardarelli, N; Cascinu, S; Catalano, G; Giordani, P; Graziano, F; Marcellini, M; Menichetti, ET | 1 |
| Arisawa, J; Hosoki, T; Inoue, Y; Masuzawa, M; Monden, M; Monden, T; Nakamura, H; Nakao, N; Ohi, H; Ohsaki, Y; Sakon, M; Seki, K; Shimizu, T; Todo, A; Tomono, N; Yayoi, E | 1 |
| Balduini, CL; Da Prada, GA; della Cuna, GR; Dornini, G; Livraghi, A; Noris, P; Pedrazzoli, P; Perotti, C; Salvaneschi, L; Torretta, L; Viarengo, G | 1 |
| Arnoud, L; Belichard, C; Coudert, B; Darut-Jouve, A; Guerrin, J; Jolimoy, G | 1 |
| Ardizzoia, A; Barni, S; Giani, L; Lissoni, P; Malugani, F; Mandalà, M; Paolorossi, F; Tancini, G | 1 |
| Forni, M; Kobierska, A; Piccart, MJ; ten Bokkel Huinink, WW; van der Burg, ME; van der Putten, E; Vermorken, JB | 1 |
| Bosquée, L; Canon, JL; Humblet, Y; Rosier, JF; van de Velde, H; Weynants, P | 1 |
| Bekradda, M; Bensmaïne, MA; Brain, E; Cvitkovic, E; Di Palma, M; Garrino, C; Goupil, A; Misset, JL; Soulié, P | 1 |
| Bláha, M; Filip, S; Mericka, P; Odrázka, K; Vávrová, J | 1 |
| de Swart, CA; Huldij, JC; Nortier, JW; Rubach, M; van Tinteren, H; van Toorn, DW; Vermorke, JB | 1 |
| Angus, B; Carey, PJ; Finney, RD; Galloway, MJ; Goff, DK; Haynes, A; Jackson, GH; Lennard, AL; Leonard, RC; McQuaker, IG; Proctor, SJ; Russell, N; Taylor, PR; Windebank, K | 1 |
| Baldelli, AM; Barni, S; Casaretti, R; Cascinu, S; Catalano, G; Catalano, V; Comella, G; Frontini, L; Graziano, F; Labianca, R | 1 |
| Bláha, M; Filip, S; Maricka, P; Medková, V; Stránský, P; Vanásek, J; Vavrová, J | 1 |
| Hosaka, M; Ikeda, I; Kawakami, S; Kubota, Y; Masuda, M; Noguchi, S; Ohuchi, H; Saito, K; Takase, K; Yao, M | 1 |
| Alietti, A; Baldini, L; Colombi, M; Guffanti, A; Latargia, ML; Maiolo, AT; Vener, C | 1 |
| Aloe, A; Carlini, P; Cognetti, F; De Marco, S; Fabi, A; Magnani, E; Nardi, M; Pacetti, U; Ruggeri, EM | 1 |
| Hada, T; Hidaka, T; Higashino, K; Moriwaki, Y; Naka, M; Nishigami, T; Takagi, S; Takahashi, S; Yamamoto, T | 1 |
| Gatzemeier, U; Hossfeld, DK; Laumen, R; Lenaz, L; Neuhauss, R; Reck, M; von Pawel, J | 1 |
| Piers, DA; Postmus, PE; Smit, EF | 1 |
| Calciati, A; de Pauw, M; Fosså, SD; Pavone-Macaluso, M; Roozendaal, KJ; Splinter, T; Sylvester, R; Veenhof, KH | 1 |
| Asaishi, K; Hayasaka, H; Mikami, T; Narimatsu, E; Okazaki, A; Okazaki, M; Okazaki, Y; Sato, H; Toda, K; Watanabe, Y | 1 |
| Fukutani, H; Hirano, A; Horikoshi, N; Inoue, K; Mizunuma, N; Mukaiyama, T; Ogawa, M; Shinagawa, K; Tabata, M | 1 |
| Sakata, Y; Yoshida, Y | 1 |
35 trial(s) available for epirubicin and Thrombopenia
| Article | Year |
|---|---|
Results of NC-6300 (Nanoparticle Epirubicin) in an Expansion Cohort of Patients with Angiosarcoma.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Hemangiosarcoma; Humans; Micelles; Nanoparticles; Neutropenia; Polymers; Proteins; Thrombocytopenia | 2022 |
A randomized and open-label phase II trial reports the efficacy of neoadjuvant lobaplatin in breast cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Axilla; Cyclobutanes; Docetaxel; Epirubicin; Female; Follow-Up Studies; Humans; Mammary Glands, Human; Middle Aged; Neoadjuvant Therapy; Odds Ratio; Organoplatinum Compounds; Remission Induction; Taxoids; Thrombocytopenia; Treatment Outcome; Triple Negative Breast Neoplasms | 2018 |
Neoadjuvant chemotherapy with paclitaxel and everolimus in breast cancer patients with non-responsive tumours to epirubicin/cyclophosphamide (EC) ± bevacizumab - results of the randomised GeparQuinto study (GBG 44).
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Epirubicin; Everolimus; Exanthema; Female; Humans; Mastectomy, Segmental; Middle Aged; Mucositis; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Sirolimus; Thrombocytopenia; Treatment Outcome | 2013 |
A multicenter phase I-II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Diarrhea; Disease-Free Survival; Docetaxel; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplastic Cells, Circulating; Neutropenia; Receptor, ErbB-2; Survival Rate; Taxoids; Thrombocytopenia; Young Adult | 2013 |
[Epirubicin combined with DDP and 5-Fu for treatment of advanced gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Neutropenia; Palliative Care; Retrospective Studies; Stomach Neoplasms; Survival Rate; Thrombocytopenia | 2009 |
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Filgrastim; Fluorouracil; Glutathione; Granulocyte Colony-Stimulating Factor; Humans; Leucovorin; Leukopenia; Levoleucovorin; Male; Middle Aged; Neoadjuvant Therapy; Recombinant Proteins; Stomach Neoplasms; Thrombocytopenia; Treatment Outcome | 2004 |
Paclitaxel, epirubicin and cyclophosphamide combination in first-line treatment of metastatic breast cancer: a dose escalation study.
Topics: Adult; Aged; Anemia; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Hematologic Diseases; Hospitalization; Humans; Middle Aged; Neutropenia; Paclitaxel; Stroke Volume; Survival Analysis; Thrombocytopenia; Treatment Outcome; Ventricular Function, Left | 2004 |
Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Neutropenia; Prednisone; Prospective Studies; Pyruvaldehyde; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2005 |
A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Injections, Intravenous; Leukopenia; Male; Mesothelioma; Middle Aged; Neutropenia; Pleural Neoplasms; Quality of Life; Remission Induction; Ribonucleotide Reductases; Survival Rate; Thrombocytopenia; Treatment Outcome | 2008 |
Randomized study for the treatment of adult advanced Hodgkin's disease: epirubicin, vinblastine, bleomycin, and dacarbazine (EVBD) versus mitoxantrone, vinblastine, bleomycin, and dacarbazine (MVBD).
Topics: Actuarial Analysis; Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemical and Drug Induced Liver Injury; Dacarbazine; Epirubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Mitoxantrone; Prospective Studies; Thrombocytopenia; Treatment Outcome; Ventricular Function, Left; Vinblastine | 1994 |
Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Double-Blind Method; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Infections; Lenograstim; Middle Aged; Neutropenia; Pharmaceutical Vehicles; Recombinant Proteins; Thrombocytopenia | 1995 |
Carboplatin in combination with epirubicin and cyclophosphamide in patients with advanced ovarian cancer. A phase II study.
Topics: Adult; Aged; Ambulatory Care; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cyclophosphamide; Disease Progression; Epirubicin; Female; Follow-Up Studies; Humans; Laparotomy; Leukopenia; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Remission Induction; Reoperation; Survival Rate; Thrombocytopenia; Vomiting | 1995 |
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task Force.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Italy; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Remission Induction; Survival Rate; Thrombocytopenia | 1993 |
Short-term administration of granulocyte-macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Humans; Methotrexate; Middle Aged; Neutropenia; Thrombocytopenia | 1993 |
Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Stomach Neoplasms; Thrombocytopenia | 1993 |
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cause of Death; Dose-Response Relationship, Drug; Drug Tolerance; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Sepsis; Thrombocytopenia | 1996 |
Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Estramustine; Gastrointestinal Diseases; Gonadotropin-Releasing Hormone; Heart Diseases; Humans; Leukopenia; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Thrombocytopenia | 1997 |
A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: a trial of the Japan Clinical Oncology Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neutropenia; Prospective Studies; Receptors, Estrogen; Recombinant Proteins; Survival Rate; Thrombocytopenia | 1997 |
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study.
Topics: Administration, Oral; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Epirubicin; Female; Humans; Indazoles; Infusions, Intravenous; Middle Aged; Nausea; Pilot Projects; Thrombocytopenia; Treatment Outcome; Vomiting | 1998 |
Phase II study of paclitaxel in pretreated advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Stomach Neoplasms; Survival Analysis; Thrombocytopenia; Time Factors | 1998 |
[Results of clinical study with epirubicin hydrochloride injectable solution in hepatoma].
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Drug Administration Schedule; Epirubicin; Fever; Hepatic Artery; Humans; Injections, Intra-Arterial; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1998 |
Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Melatonin; Middle Aged; Platelet Count; Remission Induction; Thrombocytopenia; Time Factors; Treatment Outcome | 1999 |
Phase I study of high-dose epirubicin in platinum-pretreated patients with ovarian carcinoma.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Humans; Leukopenia; Middle Aged; Ovarian Neoplasms; Thrombocytopenia; Treatment Outcome | 1999 |
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clini
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Nervous System Neoplasms; Neutropenia; Recurrence; Survival Rate; Thoracic Neoplasms; Thrombocytopenia; Treatment Outcome | 1999 |
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Epirubicin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 1999 |
Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Leukapheresis; Leukopenia; Middle Aged; Platelet Transfusion; Salvage Therapy; Stem Cells; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome | 2000 |
Randomized phase II study of FEC day 1 + 8 and FEC day 1 in patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Leukocytes; Middle Aged; Netherlands; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2000 |
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Prognosis; Remission Induction; Salvage Therapy; Survival Analysis; Thrombocytopenia; Transplantation Conditioning; Treatment Outcome | 2000 |
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Epirubicin; Fatigue; Female; Fluorouracil; Glutathione; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leucovorin; Male; Middle Aged; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids; Thrombocytopenia; Treatment Outcome | 2001 |
Intensive cyclic chemotherapy with unprocessed whole blood support in advanced breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Breast Neoplasms; Chemotherapy, Adjuvant; Cryopreservation; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Leukopenia; Middle Aged; Thrombocytopenia | 2001 |
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.
Topics: Adult; Aged; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Drug Administration Schedule; Drug Resistance, Neoplasm; Epirubicin; Humans; Lomustine; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Procarbazine; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2000 |
Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Humans; Infusions, Intravenous; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Ovarian Neoplasms; Paclitaxel; Thrombocytopenia; Treatment Outcome | 2001 |
Carboplatin/etoposide/vincristine therapy in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Drug Evaluation; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Recurrence; Thrombocytopenia; Time Factors; Vincristine | 1992 |
Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Epirubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia | 1992 |
[Phase II study of epirubicin in inoperable or recurrent gastric cancer].
Topics: Adult; Aged; Anemia; Anorexia; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms; Thrombocytopenia | 1986 |
21 other study(ies) available for epirubicin and Thrombopenia
| Article | Year |
|---|---|
Anemia requiring transfusion in breast cancer patients on dose-dense chemotherapy: Prevalence, risk factors, cost and effect on disease outcome.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Humans; Prevalence; Risk Factors; Thrombocytopenia; Treatment Outcome; Triple Negative Breast Neoplasms | 2022 |
Combination Cisplatin-Epirubicin-Paclitaxel Therapy for Metastatic Extramammary Paget's Disease.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Genital Neoplasms, Male; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Paget Disease, Extramammary; Prognosis; Progression-Free Survival; Retrospective Studies; Scrotum; Severity of Illness Index; Thrombocytopenia; Vulvar Neoplasms | 2019 |
[Treatment and prognosis of 117 patients with advanced urothelial carcinoma of the bladder].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Retrospective Studies; Survival Rate; Thrombocytopenia; Urinary Bladder Neoplasms; Urothelium | 2014 |
Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Topics: Adolescent; Age Factors; Anemia; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Incidence; Male; Mesna; Neutropenia; Rhabdomyosarcoma; Sex Characteristics; Survival Rate; Thrombocytopenia; Vincristine; Young Adult | 2012 |
Prognostic value of platelet count in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Neutropenia; Platelet Count; Prednisolone; Prognosis; Retrospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Young Adult | 2012 |
Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?
Topics: Aged; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Dexamethasone; Disease Progression; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Hormones; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Thrombocytopenia; Time Factors; Treatment Outcome | 2005 |
Anticoagulant-induced pseudothrombocytopenia occurring after transcatheter arterial embolization for hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Anticoagulants; Blood Platelets; Carcinoma, Hepatocellular; Disseminated Intravascular Coagulation; Edetic Acid; Embolization, Therapeutic; Epirubicin; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Neoplasm Invasiveness; Platelet Count; Portal Vein; Thrombocytopenia | 2006 |
[CEOP regimen in the treatment for non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Remission Induction; Retrospective Studies; Survival Analysis; Thrombocytopenia; Vincristine | 2007 |
Phase II trial of 4'epi-adriamycin for advanced hypernephroma.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Kidney Neoplasms; Leukopenia; Male; Middle Aged; Thrombocytopenia | 1983 |
4'-Epi-Doxorubicin -- a clinical phase-II trial in solid tumors.
Topics: Adult; Aged; Alopecia; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Kidney Neoplasms; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Testicular Neoplasms; Thrombocytopenia | 1984 |
A phase-II clinical trial of 4'-epi-doxorubicin in advanced solid tumors.
Topics: Adult; Aged; Anemia; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation; Epirubicin; Female; Heart; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Stroke Volume; Thrombocytopenia | 1984 |
[A phase I trial of 4'-epiadriamycin].
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Stomach Neoplasms; Thrombocytopenia | 1984 |
M-VEC (methotrexate, vinblastine, 4'-epirubicin and cisplatin) combined with glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the treatment of transitional cell carcinoma of urothelium: reduction in toxicity produced by r
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Epirubicin; Female; Glycosylation; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Recombinant Proteins; Survival Analysis; Thrombocytopenia; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Eclampsia after polychemotherapy for nodal-positive breast cancer during pregnancy.
Topics: Adult; Antibiotics, Antineoplastic; Anticonvulsants; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Eclampsia; Epirubicin; Female; Fluorouracil; Gestational Age; Humans; Hypertension; Placenta; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Proteinuria; Thrombocytopenia; Trophoblasts | 1996 |
Autologous platelet collection and storage to support thrombocytopenia in patients undergoing high-dose chemotherapy and circulating progenitor cell transplantation for high-risk breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Blood Preservation; Blood Transfusion, Autologous; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Methotrexate; Platelet Transfusion; Thiotepa; Thrombocytopenia | 1998 |
[Neoadjuvant chemotherapy FEC-HD in locally advanced breast cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Thrombocytopenia | 1999 |
[Study of neoadjuvant chemotherapy for invasive bladder cancer with MEC (methotrexate, epirubicin, cisplatin) therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Drug Administration Schedule; Epirubicin; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Prognosis; Survival Analysis; Thrombocytopenia; Urinary Bladder Neoplasms | 2001 |
Malignant lymphoma in the mesentery with immune thrombocytopenia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Humans; Immunoglobulin G; Lymphoma, Non-Hodgkin; Male; Mesentery; Peritoneal Neoplasms; Platelet Count; Prednisolone; Thrombocytopenia; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 1992 |
A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Thrombocytopenia; Urinary Bladder Neoplasms | 1989 |
[Intra-arterial infusion chemotherapy of advanced breast cancer--effects and side effects of adriamycin, 4'-epi-adriamycin and THP-adriamycin].
Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Lymphatic Metastasis; Remission Induction; Thrombocytopenia | 1989 |
[Phase II study of combination chemotherapy with epirubicin, cyclophosphamide and ftorafur in metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Middle Aged; Neoplasm Metastasis; Tegafur; Thrombocytopenia | 1988 |